CUL2 and myeloid sarcoma: The functions and diseases associated with the CD8+ T cell csDMPs identified in this study suggest they are markers of pregnancy outcomes, rather than genes implicated in the modulation of MS outcomes due to pregnancy (e.g. OR2L1, HOOK2 and CUL2).